The sequential antifracturative treatment: a meta-analysis of randomized clinical trials

CONCLUSION: The Task Force formulated recommendations on sequential therapy, which is the first treatment with anabolic drugs or 'bone builders' in patients with very high or imminent risk of fracture.PMID:38654732 | PMC:PMC11036926 | DOI:10.1177/1759720X241234584
Source: Adv Data - Category: Epidemiology Authors: Source Type: research